Combination therapy with nucleoside analogs and alkylators in Waldenström macroglobulinemia
Study . | No. patients . | Regimen . | ORR, % . | Response duration, mo . |
|---|---|---|---|---|
| Tam et al14 | 9 | Fludarabine/cyclophosphamide | 88 | 13 |
| LeBlond et al20 | 49 | Fludarabine/cyclophosphamide | 78 | 27 |
| Weber et al12 | 37 | Cladribine/cyclophosphamide | 84 | 36 |
| Dimopoulos et al16 | 11 | Dexamethasone/cyclophosphamide/rituximab | 55 | NA |
Study . | No. patients . | Regimen . | ORR, % . | Response duration, mo . |
|---|---|---|---|---|
| Tam et al14 | 9 | Fludarabine/cyclophosphamide | 88 | 13 |
| LeBlond et al20 | 49 | Fludarabine/cyclophosphamide | 78 | 27 |
| Weber et al12 | 37 | Cladribine/cyclophosphamide | 84 | 36 |
| Dimopoulos et al16 | 11 | Dexamethasone/cyclophosphamide/rituximab | 55 | NA |
NA indicates not applicable.